0 items USD 0.00Search
Your search for "globaldata leishmaniasis kala azar global clinical trials review h1 2015" gave back 48391 results.
Summary Drugs for Leishmaniasis (Kala-Azar) market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
February 2020
Price: USD 2,960.00
Summary Drugs for Leishmaniasis (Kala-Azar) market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
February 2021
Price: USD 2,960.00
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species,...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Cutaneous Leishmaniasis Drugs market size was valued at US$ 42 million in 2023. With growing demand in downstream market, the Cutaneous...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Cutaneous leishmaniasis is the most common syndrome and can produce ulcers that have the potential of stimulating a periosteal reaction if the ulcer...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Cutaneous Leishmaniasis Drugs market size was valued at USD 44 million in 2023 and is forecast to a readjusted size of USD 58 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Publisher' newest research report, the “Cutaneous Leishmaniasis Medication Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
January 2023
Price: USD 3,660.00
A drug used to treat diseases caused by parasitic protozoa leishmania The “Leishmaniasis Treatment Industry Forecast” looks at past sales and reviews...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Cutaneous and Systemic Leishmaniasis is the most common syndrome and can produce ulcers that have the potential of stimulating a periosteal reaction...
Catalog:
LPI
March 2023
Price: USD 3,660.00
According to our Publisher latest study, the global Cutaneous Leishmaniasis Medication market size was valued at USD million in 2022 and is forecast...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Neuropathic Eye Pain market size is projected to grow from US$ 148.7 million in 2022 to US$ 186 million in 2029; it is expected to grow at...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Summary Clinical Trial Management System market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
October 2020
Price: USD 2,960.00
The global Neuropathic Eye Pain market size was valued at USD 156.4 million in 2022 and is forecast to a readjusted size of USD 192.3 million by 2029...
Catalog:
GIR
June 2023
Price: USD 3,480.00
